Precigen, Inc. (PGEN) Financials

PGEN Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 138.6 million 118.4 million
Dec. 31, 2025 156.6 million 135.7 million
Sept. 30, 2025 171.3 million 129.4 million
June 30, 2025 101.9 million 138.7 million

PGEN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -44.1 million 3.0 million
Dec. 31, 2025 -24.1 million 2.2 million
Sept. 30, 2025 -29.5 million 4.4 million
June 30, 2025 -19.9 million 1.6 million

PGEN Net Income

No data available :(

PGEN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 56.2 million 93.5 million 3.7 million
Dec. 31, 2025 97.9 million - 4.0 million
Sept. 30, 2025 121.1 million 92.9 million 5.3 million
June 30, 2025 59.8 million - 5.2 million

PGEN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 313.0 million
Dec. 31, 2025 313.0 million
Sept. 30, 2025 296.4 million
June 30, 2025 296.4 million

PGEN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 258000 5.3 million 21.0 million -
Dec. 31, 2025 622000 6.7 million 17.6 million -
Sept. 30, 2025 389000 12.1 million 24.0 million -
June 30, 2025 966000 11.5 million 16.1 million -

PGEN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 23.3 million 2.9 million
Dec. 31, 2025 4.6 million 1.9 million
Sept. 30, 2025 2.9 million 1.4 million
June 30, 2025 856000 1.6 million

PGEN Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PGEN

Price: $4.80

52 week price:
1.30
5.47

Payout Ratio Range:
-244.87%
-0.02%

Earnings Per Share: -1.21 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 4.3 million

Market Capitalization: 1.1 billion

Links: